Status:

ACTIVE_NOT_RECRUITING

Efficacy and Safety of Laparoscopic Lateral Suspension and Transvaginal Sacrospinous Ligament Fixation in Patients With Pelvic Organ Prolapse

Lead Sponsor:

Peking University People's Hospital

Conditions:

Pelvic Organ Prolapse (POP)

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

This study is a single-center, non-blinded, non-inferiority randomized controlled trial, planning to recruit 86 patients with Stage III or higher pelvic organ prolapse who are unresponsive to conserva...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years;
  • According to the POP-Q classification, patients who meet any of the following conditions: a. Patients with anterior wall prolapse of stage III or higher; b. Patients with apical prolapse of stage III or higher;
  • Patients who refuse conservative treatment or have ineffective conservative treatment and request surgical treatment for prolapse;
  • Patients who voluntarily participate in this study, sign the informed consent form, and are able to attend follow-up visits on time;
  • Patients who have received education at the primary school level or above;
  • Patients who are able to visit the hospital for examinations;
  • Patients who are deemed fit to undergo surgery according to preoperative anesthesia assessment.

Exclusion

  • Patients who have previously undergone surgery for pelvic organ prolapse (POP);
  • Patients with a history of anti-incontinence surgery or who are planned to undergo mid-urethral sling surgery for anti-incontinence during the current operation;
  • Patients who, after evaluation by the surgeon, have other conditions that affect eligibility for inclusion.

Key Trial Info

Start Date :

April 5 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 31 2026

Estimated Enrollment :

86 Patients enrolled

Trial Details

Trial ID

NCT06903988

Start Date

April 5 2025

End Date

August 31 2026

Last Update

November 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Peking University People's Hospital

Beijing, China, 100044